New Antipsychotic Medications in the Last Decade
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Link
https://link.springer.com/content/pdf/10.1007/s11920-021-01298-w.pdf
Reference203 articles.
1. • Kalin NH. Developing innovative and novel treatment strategies. Am J Psychiatry. 2019;176(11):885–7.
2. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
3. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
4. McCormack PL. Cariprazine: first global approval. Drugs. 2015;75(17):2035–43.
5. Seneca N, Finnema SJ, Laszlovszky I, Kiss B, Horvath A, Pasztor G, et al. Occupancy of dopamine D(2) and D(3) and serotonin 5-HT(1)A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography. Psychopharmacology. 2011;218(3):579–87.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer’s Disease;2024-01-24
2. Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023;Molecules;2023-12-21
3. Crystal structure and X-ray powder diffraction data for Lumateperone tosylate;Powder Diffraction;2023-10-27
4. Creation of a ready-to-use brexpiprazole suspension and the inflammation-mediated pharmacokinetics by intramuscular administration;European Journal of Pharmaceutics and Biopharmaceutics;2023-08
5. Formulation Development and Molecular Mechanism Characterization of Long-Acting Patches of Asenapine for Efficient Delivery by Combining API-ILs Strategy and Controlled-Release Polymers;Journal of Pharmaceutical Sciences;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3